By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Key Statistics

Ownership: Public

Web Site: BioTime
Symbol: BTX

Company News
BioTime (BTX) Release: Additional Data From Company’s OpRegen Clinical Trial in Dry-AMD to be Presented At ARVO 2017 1/19/2017 7:46:54 AM
BioTime (BTX) and Subsidiary Cell Cure Neurosciences Ltd. Establish Innovative Cell Therapy Manufacturing Center in Israel 1/3/2017 6:38:46 AM
BioTime (BTX) Achieves Patient Recruitment Milestone In Renevia Pivotal Trial 12/14/2016 10:10:16 AM
Positive Early Data From BioTime (BTX)’s Renevia Pivotal Trial Presented At IFATS Meeting 11/18/2016 11:46:16 AM
BioTime (BTX) Reports Third Quarter Results And Recent Clinical Progress 11/4/2016 10:54:45 AM
BioTime (BTX) Appoints Industry Veteran Jim Knight As Senior Vice President, Head Of Corporate Development 10/31/2016 9:40:55 AM
BioTime (BTX) To Announce Third Quarter Results On November 3, 2016 10/24/2016 11:02:50 AM
First Patient Cohort Data From BioTime (BTX)'s OpRegen Clinical Trial In Dry-AMD To Be Presented At ISOPT Clinical Symposium On December 2, 2016 10/20/2016 1:22:16 PM
BioTime (BTX) To Present At The BIO Investor Forum 10/13/2016 11:49:44 AM
BioTime (BTX) To Webcast Presentation At The Ladenburg Thalmann 2016 Healthcare Conference 9/23/2016 10:38:03 AM